Hydromer, Inc., a leader in hydrophilic, thromboresistant and antimicrobial coating technologies, announced its expansion into the manufacturing and global supply of automated high-speed coating and UV curing equipment. This strategic move integrates the company's proprietary coatings with high-performance machinery to create a comprehensive, end-to-end solution for medical device manufacturers worldwide.
The integrated platform allows manufacturers to correlate process parameters directly with performance outcomes, supporting compliance with ISO 13485 and FDA Quality System Regulations (21 CFR Part 820). By controlling both the coating formulations and the application equipment, Hydromer aims to eliminate technical barriers that often delay product development and market entry.
The expanded equipment platform includes several key systems designed to enhance manufacturing efficiency. The Hydrophilic Coating Equipment delivers uniform coating application and UV curing with minimal manual intervention. The Automated High-Throughput Coating System features a modular design comprised of load, dip coating and UV curing workstations that can be operated by a single operator to increase production rates and reduce reliance on manual labor. Additionally, the company offers Friction Testing Equipment designed for lubricity tests with precise and repeatable measurements to support performance evaluation and quality control.
"Hydromer has long been focused on coating performance and manufacturing consistency," said Michael Torti, CEO of Hydromer. "By manufacturing and supplying the equipment used to apply our industry-leading hydrophilic coatings, we eliminate technical barriers and help our clients reduce time to market while maintaining the highest standards of quality and regulatory confidence."
This expansion represents a significant shift in Hydromer's business model from primarily providing coating formulations to offering complete manufacturing solutions. The company's four decades of experience in surface modification and coating technologies positions it to address growing demands for automation and standardization in medical device manufacturing. The move comes as manufacturers face increasing pressure to improve production efficiency while maintaining strict quality standards required by regulatory bodies worldwide.
For business and technology leaders in the medical device industry, Hydromer's expansion offers potential solutions to several persistent challenges. The integrated approach could reduce the complexity of implementing advanced coating technologies, minimize validation requirements, and accelerate production scaling. As regulatory requirements continue to evolve, having a single provider responsible for both materials and application processes may simplify compliance documentation and quality assurance procedures.
The original announcement can be viewed on www.newmediawire.com.
